In Medicaid, generic drug cost containment revolves around two programs: the Federal upper limit (FUL) program and State maximum allowable cost (MAC) programs. This article analyzes MAC programs in five States and finds considerable variation between these programs and the FUL program in both size and pricing aggressiveness. We conclude that expansion of existing MAC programs and creation of new ones could contribute to cost containment efforts nationwide. Options for States seeking to optimize their efforts include focusing on pricing for drugs with high sales volumes, ensuring that MAC lists include prices for all forms and dosages of listed drug entities, and collaborating with other States or the Federal Government on MAC list operations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194860PMC

Publication Analysis

Top Keywords

mac programs
16
cost containment
12
generic drug
8
drug cost
8
ful program
8
mac
6
programs
6
cost
4
containment medicaid
4
medicaid lessons
4

Similar Publications

Dynamic switching of transmission modes hydroacoustic communication MAC protocols.

Sci Rep

December 2024

CETC POTEVIO SCIENCE & TECHNOLOGY CO., LTD, Guangzhou, 510310, P.R. China.

In recent years, the hydroacoustic communication MAC (Medium Access Control) protocol has attracted wide attention. Hydroacoustic communication networks suffer from issues such as long propagation delays and rapid dynamic changes in network load, which prevent the maximization of network performance through the use of a single transmission mode. In this paper, we propose a Dynamic Switching Transmission MAC protocol called the DSTM-MAC protocol.

View Article and Find Full Text PDF

Chemotherapy is widely used to treat lung adenocarcinoma (LUAD) patients comprehensively. Considering the limitations of chemotherapy due to drug resistance and other issues, it is crucial to explore the impact of chemotherapy and immunotherapy on these aspects. In this study, tumor samples from nine LUAD patients, of which four only received surgery and five received neoadjuvant chemotherapy, were subjected to scRNA-seq analysis.

View Article and Find Full Text PDF

SGLT-2i and GLP-1RA are recommended for persons with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD) but are underused in clinical practice. The COORDINATE-Diabetes randomized clincal trial evaluated a multi-faceted intervention to increase the use of evidence-based therapies for reducing cardiovascular risk among participants with diabetes and atherosclerotic cardiovascular disease. This analysis reports the discontinuation rate of SGLT-2i and GLP-1RA in follow up and summarises the clinician-reported reasons underlying these decisions.

View Article and Find Full Text PDF

Animal genomes are packaged into chromatin, a highly dynamic macromolecular structure of DNA and histone proteins organised into nucleosomes. This accommodates packaging of lengthy genomic sequences within the physical confines of the nucleus while also enabling precise regulation of access to genetic information. However, histones existed before chromatin and have lesser-known functions beyond genome regulation.

View Article and Find Full Text PDF

Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia.

Genes Immun

December 2024

Translational Immunology Research Program, Research Programs Unit and Bacteriology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Preeclampsia is a common multifactorial disease of pregnancy. Dysregulation of complement activation is among emerging candidates responsible for disease pathogenesis. In a targeted exomic sequencing study of 609 women with preeclampsia and 2092 non-preeclamptic controls, we identified 14 variants within nine genes coding for components of the membrane attack complex (MAC, C5b-9) that are associated with preeclampsia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!